Cytological changes in nasal secretions accompanying delayed nasal response to allergen challenge

American Journal of Rhinology and Allergy

Volumn 27, Issue 5, 2013, Pages 345-353

  Pelikan, Zdenek ^a  

^a Allergy Research Foundation   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; GAMMA INTERFERON; INTERLEUKIN 4;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; BASOPHIL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; DELAYED HYPERSENSITIVITY; DERMATOPHAGOIDES; EOSINOPHIL; FEMALE; GOBLET CELL; HUMAN; LYMPHOCYTE COUNT; MALE; MAST CELL; MONOCYTE; NASAL LAVAGE; NASAL PRURITUS; NEUTROPHIL COUNT; NOSE ALLERGY; NOSE PROVOCATION TEST; NOSE SECRETION; PLASMA CELL; SKIN TEST; SNEEZING; THROMBOCYTE COUNT;

ADULT; ALLERGENS; FEMALE; GOBLET CELLS; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTES; MALE; NASAL LAVAGE FLUID; NASAL MUCOSA; NASAL PROVOCATION TESTS; YOUNG ADULT;

EID: 84888417130     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3933a     Document Type: Article

References (55)

1. Andersson M, Greiff L, Svensson C, et al. Allergic and nonallergic rhinitis. In Asthma and Rhinitis. Busse WW, and Holgate ST (Eds). Oxford, London, Edinburgh, Melbourne, Paris, Berlin, Vienna: Blackwell Science Publishing, 145-155, 1995.
2. Creticos PS. Allergic rhinitis. In Asthma and Rhinitis. Busse WW, and Holgate ST (Eds). Oxford, London, Edinburgh, Melbourne, Paris, Berlin, Vienna: Blackwell Science Publishing, 1394-1414, 1995.
3. Orban NT, Saleh H, and Durham SR. Allergic and non-allergic rhinitis. In Middleton's Allergy, Principles & Practice, 7th ed. Adkinson NF, Bochner BS, Busse WW, et al. (Eds). Philadelphia, PA: Mosby Elsevier, 973-990, 2009.
4. Pelikan Z. The late nasal response-Its clinical and immunologic features, possible mechanisms and pharmacologic modulation. Thesis, Free University Amsterdam, 1-384, 1996.
5. Pelikan Z. Diagnostic value of nasal allergen challenge combined with radiography and ultrasonography in chronic maxillary sinus disease. Arch Otolaryngol Head Neck Surg 135:1246-1255, 2009.
6. Pelikan Z. Seasonal and perennial allergic conjunctivitis: The possible role of nasal allergy. Clin Exp Ophthalmol 37:448-457, 2009.
7. Miadonna A, Milazzo N, Gibelli S, et al. Nasal response to a single antigen challenge in patients with allergic rhinitis-inflammatory cell recruitment persists up to 48 hours. Clin Exp Allergy 29:941-949, 1999.
8. + cells in human allergic diseases. J Allergy Clin Immunol 100:1-6, 1997.
9. Varney VA, Jacobson MR, Sudderick RM, et al. Immunohistology of the nasal mucosa following allergen-induced rhinitis. Identification of activated T lymphocytes, eosinophils, and neutrophils. Am Rev Respir Dis 146:170-176, 1992.
10. Gaga M, Frew AJ, Varney VA, and Kay AB. Eosinophil activation and T lymphocyte infiltration in allergen-induced late phase skin reactions and classical delayed-type hypersensitivity. J Immunol 147:816-822, 1991.
11. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy 41:37-47, 1978.
12. Pelikan Z, and Pelikan-Filipek M. Cytologic changes in the nasal secretions during the immediate nasal response. J Allergy Clin Immunol 82:1103-1112, 1988.
13. Pelikan Z, and Pelikan-Filipek M. Cytologic changes in the nasal secretion during the late nasal response. J Allergy Clin Immunol 83:1068-1079, 1989.
14. Bascom R, Pipkorn U, Lichtenstein LM, and Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis 138:406-412, 1988.
15. Pipkorn U, Karlsson G, and Enerback L. Nasal mucosal response to repeated challenges with pollen allergen. Am Rev Respir Dis 140:729-736, 1989.
16. Malmberg H, and Holopainen E. Nasal smear as a screening test for immediate-type nasal allergy. Allergy 34:331-337, 1979.
17. Bascom R, Wachs M, Naclerio RM, et al. Basophil influx occurs after nasal antigen challenge. Effects of topical corticosteroid pretreatment. J Allergy Clin Immunol 81:580-589, 1988.
18. Walden SM, Proud D, Bascom R, et al. Experimentally induced nasal allergic responses. J Allergy Clin Immunol 81:940-949, 1988.
19. Illiopoulos O, Proud D, Adkinson NF, et al. Relationship between the early, late and rechallenge reaction to nasal challenge with allergen: Observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol 86:851-861, 1990.
20. Mygind N. Nasal Allergy, 2nd ed. Oxford, U.K.: Blackwell Science Publishing, 155-169, 199-216, 1979.
21. Howarth PH, Persson CG, Meltzer EO, et al. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol 115:S414-S441, 2005.
22. Ciprandi G, Tosca MA, Marseglia GL, and Klersy C. Relationships between allergic inflammation and nasal airflow in children with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 94:258-261, 2005.
23. Jirapongsananuruk O, and Vichyanond P. Nasal cytology in the diagnosis of allergic rhinitis in children. Ann Allergy Asthma Immunol 80:165-170, 1998.
24. Belda J, Parameswaran K, Keith PK, and Hargreave FE. Repeatability and validity of cell and fluid-phase measurements in nasal fluid: A comparison of two methods of nasal lavage. Clin Exp Allergy 31:1111-1115, 2001.
25. Meltzer EO, Orgel HA, and Jalowayski AA. Nasal cytology. In Rhinitis: Mechanisms and Management. Naclerio RM, Durham SR, and Mygind N (Ed). New York, NY: Marcel Dekker, Inc., 175-196, 1999.
26. Di Lorenzo G, Mansueto P, Pacor ML, et al. Clinical importance of eosinophil count in nasal fluid in patients with allergic and non-allergic rhinitis. Int J Immunopathol Pharmacol 22:1077-1087, 2009.
27. Lee HS, Majima Y, Sakakura Y, et al. Quantitative cytology of nasal secretions under various conditions. Laryngoscope 103:533-537, 1993.
28. Takeuchi K, Ukai K, Lee HS, et al. Quantitative cytology of nasal secretions and scrapings in Japanese cedar pollinosis patients. Laryngoscope 106:1419-1423, 1996.
29. D'Costa GF, Candes AF, and Shedge R. Quantitative cytology of nasal secretion and scrapings in children with perennial allergic rhinitis. Bombay Hospital J 51:422-426, 2009.
30. Besancon-Watelet C, Bene MC, Montagne P, et al. Eosinophilia and cell activation mediators in nasal secretions. Laryngoscope 112:43-46, 2002.
31. Jean R, Delacourt C, Rufin P, et al. Nasal cytology in rhinitis children: Comparison between brushing and blowing the nose. Allergy 51:932-934, 1996.
32. Pignatti P, Pala G, Pisati M, et al. Nasal blown secretion evaluation in specific occupational nasal challenges. Int Arch Occup Environ Health 83:217-223, 2010.
33. Castano R, Theriault G, Maghni K, et al. Reproducibility of nasal lavage in the context of the inhalation challenge investigation of occupational rhinitis. Am J Rhinol 22:271-275, 2008.
34. Juliusson S, Pipkorn U, Karlsson G, and Enerbäck L. Mast cells and eosinophils in the allergic mucosal response to allergen challenge: Changes in distribution and signs of activation in relation to symptoms. J Allergy Clin Immunol 90:898-909, 1992.
35. Pelikan Z. Histologic changes in the nasal mucosa during the immediate (INR), late (LNR) and delayed (DNR) nasal response to allergen challenge. Allergy Clin Immunol News Suppl 1:132, 1991 (Abs).
36. Pelikan Z. The effects of disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDA) on the delayed nasal mucosa response to allergen challenge. Ann Allergy 52:111-124, 1984.
37. Pelikan Z, and Pelikan-Filipek M. Cytologic changes in the nasal secretions (NS) during the delayed nasal response to allergen challenge (DNR). Clin Exp Allergy 20(suppl 1):27, 1990.
38. Pelikan Z, and Pelikan-Filipek M. Cytologic changes in nasal secretions (NS) during the delayed nasal response (DNR) pretreated with disodium cromoglycate (DSCG) and beclomethasone dipropionate (BDA) or budesonide (BSA). Allergy Clin Immunol News Suppl 1:334, 1991 (Abs).
39. Melillo G, Bonini S, Cocco G, et al. Provocation tests with allergens. Allergy 52(suppl 35):5-36, 1997.
40. Pelikan Z, Bruijnzeel PLB, and Verhagen J. Leukotrienes (LTC4, LTD4, LTB4) in the nasal secretions. Ann Allergy 55:336, 1985 (Abs).
41. Pelikan Z, and Pelikan-Filipek M. Intracellular changes in some cell types in nasal secretions (NS) during the late nasal response (LNR) to allergen challenge (NPT). Clin Exp Allergy 20(suppl 1):60, 1990 (Abs).
42. Pelikan-Filipek M, and Pelikan Z. Intracellular changes in some cell types in nasal secretions (NS) accompanying the immediate nasal response (INR). J Allergy Clin Immunol 85:300, 1990 (Abs).
43. Pelikan Z, and Pelikan-Filipek M. Immediate nasal response to allergen challenge, cytologic changes in the nasal secretions and histologic changes in the nasal mucosal. In Advances in Mucosal Immunology. Mestecky J, McGhee J, Tlaskalova H, and Sterzl J (Eds). New York, NY: Plenum Press, 847-853, 1995.
44. Pelikan Z, and Pelikan-Filipek M. Late nasal response to allergen challenge, cytologic changes in the nasal secretions and histologic changes in the nasal mucosal. In Advances in Mucosal Immunology. Mestecky J, McGhee J, Tlaskalova H, and Sterzl J (Eds). New York, NY: Plenum Press, 855-860, 1995.
45. Pelikan Z. Late type of the nasal allergic response-Review. Scripta Medica (Brmo, CZ) 74:303-344, 2001.
46. Pelikan Z. Late nasal response (LNR)-Its characteristics, feature and possible mechanism(s). In Late Phase Allergic Reactions. Dorsch W (Ed). Boca Raton, Ann Arbor, Boston: CRC Press, 111-155, 1990.
47. Pelikan Z, and Pelikan-Filipek M. The effects of disodium cromoglycate and beclomethasone dipropionate on the immediate response of the nasal mucosa to allergen challenge. Ann Allergy 49:283-292, 1982.
48. Pelikan Z. The effects of disodium cromoglycate and beclomethasone dipropionate on the late nasal mucosa response to allergen challenge. Ann Allergy 49:200-212, 1982.
49. Jalowayski AA, and Zeiger RS. Examination of nasal secretions; examination of nasal or conjunctival epithelium specimens. In Manual of Allergy and Immunology, 4th ed. Adelman DC, Casale TB, and Corren J (Eds). Philadelphia, PA: Lippincott, Williams & Wilkins, 487-490, 2002.
50. Ong Y-E, and Kay AB. Late-phase allergic reactions in humans. In Allergy and Allergic Diseases, 2nd ed. Kay AB, Kaplan AP, Bousquet J, and Holt PG (Eds). Chichester (West Sussex), U.K.: Wiley-Blackwell Publishing, Ltd., 524-550, 2008.
51. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, and Pierzchala W. Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge. Allergy Asthma Proc 32:230-238, 2011.
52. Nair P, Goodwin S, and Hargreave FE. Reproducibility, validity, and responsiveness of cell counts in blown nasal secretions. Allergy Rhinol 2:3-5, 2011.
53. Georgitis JW, Stone BD, and Gottschlich G. Inflammatory cells and mediators in nasal secretions during early response to ragweed challenge: Correlation between type of cellular influx and mediator release. Am J Rhinol 8:217-224, 1994.
54. Gelardi M, Russo C, Fiorella ML, et al. When allergic rhinitis is not only allergic. Am J Rhinol Allergy 23:312-315, 2009.
55. Pelikan Z. Histamine (HS) in nasal secretions (NS) and its changes during the basis types of nasal response (NR) to allergen challenge. Allergy 47(suppl):304, 1992.